☰

Qiang Wang - Publications

Affiliations: 
2015 Georgia State University, Atlanta, GA, United States 
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Nie C, Li Q, Qiao Y, Hu J, Gao M, Wang Y, Qiao Z, Wang Q, Yan L, Qian H. Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide. European Journal of Medicinal Chemistry. 194: 112236. PMID 32217416 DOI: 10.1016/J.Ejmech.2020.112236  0.357
2019 Wang Y, Su L, Wang Q, Zhang L, Luan Y. Novel histone deacetylase inhibitors bearing a 4-piperidin-4-yl-triazole scaffold as antitumor agents. Drug Development Research. PMID 31580523 DOI: 10.1002/Ddr.21603  0.351
2019 Li J, Nie C, Qiao Y, Hu J, Li Q, Wang Q, Pu X, Yan L, Qian H. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists. European Journal of Medicinal Chemistry. 178: 433-445. PMID 31202991 DOI: 10.1016/J.Ejmech.2019.06.007  0.328
2018 Wu G, Qi X, Mo X, Yu G, Wang Q, Zhu T, Gu Q, Liu M, Li J, Li D. Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus. European Journal of Medicinal Chemistry. 148: 268-278. PMID 29466776 DOI: 10.1016/J.Ejmech.2018.02.041  0.349
2017 Mou J, Luan Y, Chen D, Wang Q. Novel L-arginine derivatives as aminopeptidase N inhibitors: design, chemistry, and pharmacological evaluation Medicinal Chemistry Research. 26: 3015-3025. DOI: 10.1007/S00044-017-1999-2  0.387
2015 Zhang L, Han Y, Jiang Q, Wang C, Chen X, Li X, Xu F, Jiang Y, Wang Q, Xu W. Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy. Medicinal Research Reviews. 35: 63-84. PMID 24782318 DOI: 10.1002/Med.21320  0.307
2015 Wang Q, Shi Q, Huang L. Novel Aminopeptidase N Inhibitors with Improved Antitumor Activities Letters in Drug Design & Discovery. 13: 98-106. DOI: 10.2174/1570180812666150611190608  0.35
2013 Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X. Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors. Bioorganic & Medicinal Chemistry. 21: 7752-62. PMID 24247003 DOI: 10.1016/J.Bmc.2013.10.016  0.338
2012 Li Q, Fang H, Wang X, Hu G, Wang Q, Xu W. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Bioorganic & Medicinal Chemistry Letters. 22: 850-3. PMID 22206607 DOI: 10.1016/J.Bmcl.2011.12.048  0.418
2011 Luan Y, Wang Q, Liu N, Mou J, Jiao X, Fang H, Li M, Xu W. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor Anti-Cancer Drugs. 22: 99-103. PMID 21048494 DOI: 10.1097/Cad.0B013E32833Ab78A  0.362
2010 Wang Q, Xu F, Mou J, Zhang J, Shang L, Luan Y, Yuan Y, Liu Y, Li M, Fang H, Wang B, Xu W. Design, synthesis and preliminary activity evaluation of novel L-lysine derivatives as aminopeptidase N/CD13 inhibitors. Protein and Peptide Letters. 17: 847-53. PMID 20156182 DOI: 10.2174/092986610791306661  0.574
2010 Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 18: 887-95. PMID 19969464 DOI: 10.1016/J.Bmc.2009.11.036  0.404
2009 Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13. Bioorganic & Medicinal Chemistry. 17: 7398-404. PMID 19782572 DOI: 10.1016/J.Bmc.2009.07.014  0.405
2009 Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W. Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 17: 4666-73. PMID 19454370 DOI: 10.1016/J.Bmc.2009.04.056  0.425
2009 Yang K, Wang Q, Su L, Fang H, Wang X, Gong J, Wang B, Xu W. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorganic & Medicinal Chemistry. 17: 3810-7. PMID 19423354 DOI: 10.1016/J.Bmc.2009.04.038  0.591
2009 Shang L, Fang H, Zhu H, Wang X, Wang Q, Mu J, Wang B, Kishioka S, Xu W. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 17: 2775-84. PMID 19299146 DOI: 10.1016/J.Bmc.2009.02.034  0.596
2009 Zhu H, Fang H, Cheng X, Wang Q, Zhang L, Feng J, Xu W. 3D-QSAR study of pyrrolidine derivatives as matrix metalloproteinase-2 inhibitors Medicinal Chemistry Research. 18: 683-701. DOI: 10.1007/S00044-008-9160-X  0.326
2008 Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN). Bioorganic & Medicinal Chemistry. 16: 9984-90. PMID 18996018 DOI: 10.1016/J.Bmc.2008.10.025  0.575
2008 Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry. 16: 7932-8. PMID 18718763 DOI: 10.1016/J.Bmc.2008.07.073  0.362
2008 Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 16: 5473-81. PMID 18467109 DOI: 10.1016/J.Bmc.2008.04.012  0.591
2008 Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry. 16: 5398-404. PMID 18440232 DOI: 10.1016/J.Bmc.2008.04.027  0.375
2008 Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 16: 3839-47. PMID 18304821 DOI: 10.1016/J.Bmc.2008.01.036  0.361
2008 Cheng XC, Wang Q, Fang H, Xu WF. Role of sulfonamide group in matrix metalloproteinase inhibitors. Current Medicinal Chemistry. 15: 368-73. PMID 18288991 DOI: 10.2174/092986708783497300  0.305
2008 Xu W, Cheng X, Wang Q, Fang H. Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold Current Medicinal Chemistry. 15: 374-385. DOI: 10.2174/092986708783497373  0.332
2008 Jiao J, Wang Q, Zhu HW, Fang H, Xu WF. Synthesis and biological evaluation of a new series of histone deacetylases inhibitors Chinese Chemical Letters. 19: 673-675. DOI: 10.1016/J.Cclet.2008.04.010  0.379
2007 Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors. European Journal of Medicinal Chemistry. 43: 2130-9. PMID 18362041 DOI: 10.1016/J.Ejmech.2007.12.020  0.365
2007 Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors. Bioorganic & Medicinal Chemistry. 16: 578-85. PMID 17937988 DOI: 10.1016/J.Bmc.2007.04.030  0.4
2007 Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 15: 2749-58. PMID 17287121 DOI: 10.1016/J.Bmc.2007.01.020  0.378
2006 Zhang L, Zhang J, Fang H, Wang Q, Xu W. Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors. Bioorganic & Medicinal Chemistry. 14: 8286-94. PMID 17008101 DOI: 10.1016/J.Bmc.2006.09.015  0.4
Show low-probability matches.